Member Info for Porter_

The companies Scientific Advisory Board is due to meet in December.
Looking forward to seeing what updates they can share, ahead of January's in person medical trials!

steven49 - Same copy and paste comments in multiple shares. Paid basher?
DYOR guys and girls.

Yep when the order filling and manual consolidations balancing the book to fulfil orders start appearing, that's when I get excited. Also level 2 has changed, so I've got the popcorn, perhaps even champs ready.

Great start for a Monday morning!

Choooo chooooo :)

Thanks Chris. All we need is confirmation that FinnCap have the second trial funding in place and the SP would no doubt mega rerate. Glad I got in at the bottom with you all :)

Yep, there's not much stock, just needs a small bit of volume to tip it :)

Interview confirms Oxford are working with Oz UK to design a new vaping / asthma style device to be ergonomically tailored to their patients conditions:

http://www.oz-uk-labs.com/

Trial 2 ready to go into human trials - expecting funding news anyday!!!

https://www.youtube.com/watch?v=U4fW3t_o9X8

Let me stack some more shares before we move up first Chris :P

Looks like a desperate attempt at share manipulation going on with all them 1 share sells
Probably someone panicking after they sold and piled into a dog share, realised the error of their ways and want back in to Tintra

The Tintra team are about to remind everyone why they won best performing share of the year. Some excellent results across the markets today but the battle is not over, #TNT are about to level up… BIG TIME

100%. Lucas quoted realistic targets of a Jazz Pharma takeover worth $7bn on 1 product line, when OCTP have at least 4 they want to get full approval on, with exclusivity on a library of over 400 patented pharmaceuticals to choose from.

Just that $7bn target alone could bring in $7+ a share for shareholders if the company were took private.

With in person trials now going live and FinnCap now on board, serious investors will no doubt be aware of these takeover prospects, with a serious rerating imminent and will surely want in on the opportunity of a lifetime.

DJ - Your £11.2k (buy) Unknown trade!

Doesn't suit the narrative my friend. You're destined for end of day unknown trades, along with all the other big boy legends that we're gonna party over later
:P

Patiënt to be rewarded @duster :)

Fly my angel ;P

“What is the best way to use synthetic cannabinoids?

The most common way to use synthetic cannabinoids is to smoke the dried plant material. Users also mix the sprayed plant material with marijuana or brew it as tea. Other users buy synthetic cannabinoid products as liquids to vaporize in e-cigarettes.“

Explains why the relationship with tobacco / cigarette giant, Imperial Brands is so significant.

https://www.27fchileanway.cl/how-are-cannabinoids-made/

"Lucas’s ambitions are guarded, however he quotes Jazz Pharmaceutical’s $7 billion plus takeover of GW Pharma saying “the majority of that deal was on one drug product.” Lucas’s company is working on several and he’s confident, as programmes progress, significant value will be created, and that in turn will make #OCTP attractive to a wide range of companies in terms of partnerships and who knows another Jazz type outcome?"

https://www.oxcantech.com/news-article/good-shape--good-budget-and-on-track-for-oxford-cannabinoid-technologies-holdings-

Yes even more interesting that it’s been shared by the company.
Are they trying to tell us something :)